| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aba5130b481ea5be1710d495eac3cad |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-5532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0478
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0406 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 |
| filingDate |
2017-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d42ff08ebb9aafc48a00d34a7d17af75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_108c1f4925e7abff54fa360ffbefc7a1 |
| publicationDate |
2021-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
AU-2017311510-B2 |
| titleOfInvention |
Chelated PSMA inhibitors |
| abstract |
Provided herein are compounds of Formula (I) or a pharmaceutically acceptable salt thereof. Also provided are compositions including a compound of Formula (I) together with a pharmaceutically acceptable carrier, and methods for imaging prostate cancer cells. |
| priorityDate |
2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |